References
- Orth M, Bellosta S. Cholesterol: its regulation and role in central nervous system disorders. Cholesterol 2012, 292598 (2012).
- Saher G, Quintes S, Nave KA. Cholesterol: a novel regulatory role in myelin formation. Neuroscientist 17, 79–93 (2011).
- Ferretti G, Bacchetti T. Peroxidation of lipoproteins in multiple sclerosis. J. Neurol. Sci. 311, 92–97 (2011).
- Marrie RA, Rudick R, Horwitz R et al. Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology 74, 1041–1047 (2010).
- Weinstock-Guttman B, Zivadinov R, Mahfooz N et al. Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. J. Neuroinflammation 8, 127 (2011).
- Tettey P, Simpson S Jr, Taylor B et al. An adverse lipid profile is associated with disability and progression in disability, in people with MS. Mult. Scler. pii:1352458514533162 (2014).
- Weinstock-Guttman B, Zivadinov R, Ramanathan M. Interdependence of vitamin D levels with serum lipid profiles in multiple sclerosis. J. Neurol. Sci. 311, 86–91 (2011).
- Palavra F, Marado D, Mascarenhas-Melo F et al. New markers of early cardiovascular risk in multiple sclerosis patients: oxidized-LDL correlates with clinical staging. Dis. Markers 34, 341–348 (2013).
- Weinstock-Guttman B, Zivadinov R, Horakova D et al. Lipid profiles are associated with lesion formation over 24 months in interferon-beta treated patients following the first demyelinating event. J. Neurol. Neurosurg. Psychiatry 84(11), 1186–1191 (2013).
- Giubilei F, Antonini G, Di Legge S et al. Blood cholesterol and MRI activity in first clinical episode suggestive of multiple sclerosis. Acta Neurol. Scand. 106, 109–112 (2002).
- Tettey P, Simpson S Jr, Taylor B et al. Adverse lipid profile is not associated with relapse risk in MS: results from an observational cohort study. J. Neurol. Sci. 340, 230–232 (2014).
- Miron VE, Zehntner SP, Kuhlmann T et al. Statin therapy inhibits remyelination in the central nervous system. Am. J. Pathol. 174, 1880–1890 (2009).
- Klopfleisch S, Merkler D, Schmitz M et al. Negative impact of statins on oligodendrocytes and myelin formation in vitro and in vivo. J. Neurosci. 28, 13609–13614 (2008).